- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Dixie L. Johnson
News 38 results
Recognition
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
Recognition
August 4, 2022
Benchmark Names Three King & Spalding Partners to List of Top 250 Women in Litigation
Recognition
June 1, 2022
Chambers USA 2022 Recognizes 188 K&S Lawyers and 75 K&S Practice Groups as Leaders in Their Fields
Cases & Deals
December 2, 2021
BOA Acquisition Corp. to Merge with Selina in de-SPAC Transaction
Events 11 results
Speaking Engagement
January 31, 2023
Elizabeth Morgan and Dixie Johnson to Speak During the 50th Securities Regulation Institute Conference
Speaking Engagement
June 2, 2022
Dixie Johnson to Speak at 47th ABA National Conference on Professional Responsibility
Speaking Engagement
May 25, 2022
Dixie Johnson to Speak at PLI’s 54th Annual Institute on Securities Regulation
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Insights 26 results
Article · Source: Law360
May 10, 2023
Working From Home? Beware Insider Trading, Tipping Risks
Client Alert
January 25, 2023
Working From Home? Stay Alert to Avoid Insider Trading or Tipping Liability!
Client Alert
December 20, 2021
Reviving the Holiday Gathering This Year? Avoid Adding Insider Trading Liability to the Mix.
Client Alert
September 28, 2021
SEC Enforcement of Human Capital Disclosures: The First Fingerprints